Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma

NCT05004025 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Uveal Melanoma

Interventions

DEVICE: Novocure Optune
DRUG: Opdivo
DRUG: Yervoy

Sponsor

HonorHealth Research Institute

Collaborators

[object Object]